Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

被引:136
作者
Wadenberg, MLG
Kapur, S
Soliman, A
Jones, C
Vaccarino, F
机构
[1] Univ Toronto, Sect Biopsychol, CAMH, Toronto, ON, Canada
[2] Univ Toronto, CAMH, Schizophrenia Div, PET Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
关键词
C-11]-raclopride; H-3]-raclopride; in vivo; D-2 receptor occupancy; catalepsy; conditioned avoidance response; rat;
D O I
10.1007/s002130000466
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Human positron emission tomography (PET) shows that striatal dopamine D-2 receptor occupancy predicts extrapyramidal side effects (EPS). Patients showed a clinical response with greater than or equal to 65% D-2 occupancy, but EPS only when D-2 occupancy >78%. Catalepsy and the selective suppression of conditioned avoidance response (CAR) are often used as animal models to predict EPS and antipsychotic effect, respectively. However, the quantitative relationship between striatal D-2 occupancy and effects in these models is not known. Objectives: The present study intended to investigate the relationship between animal catalepsy, suppression of CAR, and D-2 receptor blockade using a method of evaluating D-2 receptor occupancy similar in principle to that used in patients. Methods: In vivo binding of [C-11]-raclopride and [H-3]-raclopride was compared. Doses of cold raclopride were chosen to provide a D-2 occupancy from 0 to 95%. The relationship between dose/time course of catalepsy and D-2 occupancy was assessed. Effects of raclopride on conditioned avoidance response (CAR) behavior were tested. Results In vivo binding of [C-11]-raclopride compared to [H-3]-raclopride was virtually the same. Using [H-3]-raclopride, cold raclopride (0.01-0.2 mg/kg) produced 16-77% D-2 receptor occupancy and no catalepsy. Raclopride (0.5-2 mg/kg) produced 83-95% D-2 occupancy and significant catalepsy. Raclopride (2 mg/kg) produced on average 95% and 87% D-2 receptor occupancy 1 and 2 h after administration, respectively, and maximum catalepsy. D-2 occupancy at 4, 8 and 24 h was on average 58%, 46%, and 4%, respectively. No catalepsy was observed. Raclopride (0.2 mg/kg), estimated at 70-75% D-2 occupancy, produced suppression of CAR. Conclusions: In vivo D-2 occupancy measurements in rats using [H-3]-raclopride is analogous to using [C-11]-raclopride in human PET scanning. Suppression of CAR occurred at a D-2 occupancy of around 70-75%, and catalepsy at D-2 occupancy greater than or equal to 80%. Results closely resembled human studies where 65-70% D-2 occupancy was required for antipsychotic response, while >80% D-2 occupancy led to EPS. Brain mechanisms involved in mediation of catalepsy in rats and EPS in humans might indeed be similar. Both suppression of CAR in rats and antipsychotic response in humans might share an underlying construct, i.e. the need for around 70% D-2 receptor blockade.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 38 条
[1]  
AHLENIUS S, 1986, PHARMACOL BIOCHEM BE, V24, P1409, DOI 10.1016/0091-3057(86)90203-0
[2]  
BALDESSARINI RJ, 1990, PHARMACOL BASIS THER, P383
[3]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186
[4]  
Cherry S. R., 1998, Society for Neuroscience Abstracts, V24, P429
[5]   EFFICACY, SAFETY AND TOLERABILITY OF RACLOPRIDE, A SPECIFIC D2-RECEPTOR BLOCKER, IN ACUTE SCHIZOPHRENIA - AN OPEN TRIAL [J].
COOKSON, JC ;
NATORF, B ;
HUNT, N ;
SILVERSTONE, T ;
UPPFELDT, G .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 (01) :61-70
[6]   NEUROLEPTIC-INDUCED CATALEPSY AS A MODEL OF PARKINSONS-DISEASE .1. EFFECT OF DOPAMINERGIC AGENTS [J].
ELLIOTT, PJ ;
CLOSE, SP ;
WALSH, DM ;
HAYES, AG ;
MARRIOTT, AS .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1990, 2 (02) :79-89
[7]  
FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71
[8]   AN OPEN LABEL TRIAL OF RACLOPRIDE IN ACUTE SCHIZOPHRENIA - CONFIRMATION OF D2-DOPAMINE RECEPTOR OCCUPANCY BY PET [J].
FARDE, L ;
WIESEL, FA ;
JANSSON, P ;
UPPFELDT, G ;
WAHLEN, A ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :1-7
[9]   QUANTITATIVE-ANALYSIS OF D2 DOPAMINE RECEPTOR-BINDING IN THE LIVING HUMAN-BRAIN BY PET [J].
FARDE, L ;
HALL, H ;
EHRIN, E ;
SEDVALL, G .
SCIENCE, 1986, 231 (4735) :258-261
[10]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538